MediFlow 360
    Back to blog
    PI BillingMarch 4, 20264 min read

    Why your PI claim denials spiked in 2026 — and what to do about it

    James Okafor
    James Okafor
    Senior Billing Consultant
    Why your PI claim denials spiked in 2026 — and what to do about it

    If your denial rate jumped 15-20% somewhere between October 2025 and February 2026, you're not alone. Three of the largest auto carriers operating in California, Texas, and Florida quietly updated their pre-authorization requirements for soft-tissue care in Q4 of last year — and most billing teams didn't notice until the denials started piling up.

    What changed. Carriers are now requiring contemporaneous documentation of functional improvement at each visit for any treatment continuing beyond six weeks. "Patient reports feeling better" is no longer sufficient. They want range-of-motion measurements, pain scale deltas, and an updated treatment plan keyed to the original mechanism of injury. A handful of carriers are also requiring a re-evaluation note signed by a supervising provider every 30 days.

    The downstream impact. Even when the underlying care is clinically unquestionable, missing this single piece of documentation gives carriers a clean reason to deny — and they're using it. We're seeing the same providers who ran 4% denial rates in 2024 now running 18-22%, almost entirely on documentation grounds rather than medical necessity.

    What to do. Three changes meaningfully move the number:

    1. Restructure your progress note template to force functional metrics at every visit past week six. If your charting platform supports required fields, use them; if not, build a billing-side validation step that holds the claim until the note is complete. 2. Add a 30-day re-evaluation reminder to your scheduling system, so the supervising provider's note is captured before the carrier's deadline rather than after the denial. 3. Appeal aggressively in the first 30 days. Most carriers will reverse a documentation-based denial if you respond with a corrected note within their initial appeal window. After that, recovery rates drop sharply.

    The 90 seconds it takes per visit to capture proper functional metrics is dramatically cheaper than reworking a denied claim three months later — and dramatically cheaper than writing it off.

    Questions the case brings up.

    Three of the largest auto carriers in California, Texas, and Florida quietly updated their pre-authorization requirements for soft-tissue care in Q4 2025, and most billing teams didn't notice until the denials started piling up.

    Carriers now require contemporaneous documentation of functional improvement at each visit for any treatment continuing beyond six weeks — range-of-motion measurements, pain scale deltas, and an updated treatment plan keyed to the original mechanism of injury. Some also require a re-evaluation note signed by a supervising provider every 30 days.

    Appeal aggressively in the first 30 days. Most carriers will reverse a documentation-based denial if you respond with a corrected note within their initial appeal window; after that, recovery rates drop sharply.
    James Okafor
    Written by
    James Okafor — Senior Billing Consultant

    James has spent 12 years in personal injury billing, most recently as VP of revenue cycle for a multi-state imaging network.